We are live on
!
Find out more
AC
Amia Capital Portfolio holdings
AUM
$32.1M
1-Year Est. Return
0.56%
This Fund
S&P 500
This Quarter
Est. Return
+33.38%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.2M
AUM Growth
-$11.9M
(-14%)
Cap. Flow
-$30.5M
Cap. Flow
% of AUM
-41.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
36
New
1
Increased
1
Reduced
2
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras
PBR
|
+$3.56M |
| 2 |
Intel
INTC
|
+$488K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vale
VALE
|
+$8M |
| 2 |
GRFS
Grifois
GRFS
|
+$5.68M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$2.02M |
| 4 |
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
|
+$1.7M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$1.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 25.76% |
| 2 | Healthcare | 24.6% |
| 3 | Materials | 6.78% |
| 4 | Technology | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Scholar Rock
SRRK
$5.71B
| – | – |
-14,821
| Closed | -$262K |
|
27
Vertex Pharmaceuticals
VRTX
$121B
| – | – |
-5,026
| Closed | -$1.37M |
|
28
Voyager Therapeutics
VYGR
$187M
| – | – |
-14,632
| Closed | -$156K |
|
29
Wave Life Sciences
WVE
$1.12B
| – | – |
-14,211
| Closed | -$121K |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-19,972
| Closed | -$512K |
|
|
MTEM
31
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-1,254
| Closed | -$205K |
|
|
MYOV
32
DELISTED
Myovant Sciences Ltd.
MYOV
| – | – |
-25,111
| Closed | -$353K |
|
|
RDUS
33
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-38,841
| Closed | -$440K |
|
|
ALXN
34
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-7,061
| Closed | -$808K |
|
|
MYOK
35
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-6,437
| Closed | -$878K |
|
|
BBL
36
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| – | – |
-39,933
| Closed | -$1.7M |
|
Similar funds
QI
SAM
FCMI
AG
NLG
BEVI
BGDR
TAAM
Amia Capital's Q4 2020 Portfolio in Review
As of Q4 2020, Amia Capital held 36 positions worth $74.2M, down 14% from $86.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Amia Capital withdrew a net $30.5M in Q4 2020, closing 30 positions and reducing 2 holdings. Its most notable exit was Ionis Pharmaceuticals, an estimated $2.02M position sold in full.
By sector, the portfolio is most concentrated in Energy at 26% of assets, up from 11% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Amia Capital opened a new position in Intel worth $498K.
- Amia Capital's largest Q4 2020 buy was Intel: 10,000 shares worth $498K.
- Amia Capital added most to Petrobras in Q4 2020, an estimated $3.56M increase.
- Amia Capital's biggest Q4 2020 reduction was Vale, cutting an estimated $8M.
- Amia Capital fully exited Ionis Pharmaceuticals in Q4 2020, selling an estimated $2.02M.
- Amia Capital's ten largest holdings make up 100% of its $74.2M portfolio in Q4 2020.
- Amia Capital opened 1 new position and closed 30 in Q4 2020.
- Amia Capital's portfolio value fell 14% quarter-over-quarter to $74.2M.
Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.